Status:
COMPLETED
Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Brief Summary
This study is an economic evaluation of Symbicort (Budesonide/formoterol) as maintenance and reliever therapy (SMART) versus its competitive alternatives. The aims of this study are: * To estimate t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Moderate to severe asthma.
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00937066
Last Update
January 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Bogotá, Colombia